List of Tigecycline drug patents

Tigecycline is owned by Amneal.

Tigecycline contains Tigecycline.

Tigecycline has a total of 1 drug patent out of which 0 drug patents have expired.

Tigecycline was authorised for market use on 02 August, 2018.

Tigecycline is available in powder;intravenous dosage forms.

The generics of Tigecycline are possible to be released after 07 April, 2033.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9855335 AMNEAL Tigecycline composition for injection
Apr, 2033

(10 years from now)

Drugs and Companies using TIGECYCLINE ingredient

Market Authorisation Date: 02 August, 2018

Treatment: NA

Dosage: POWDER;INTRAVENOUS

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in